Panavir vaginal suppositories 200mkg, No. 5

Intravaginally.

Injected into the vagina in the evening, as deep as possible, in the supine position with slightly bent legs, 1 vaginal suppository daily for 5 days. A second course of treatment is possible after consulting a doctor.

Vaginal suppositories are translucent, from white to grayish-white, torpedo-shaped, odorless.

1 supp.

potato shoots total polysaccharides (PanavirЃ) 200 ?g

• hypersensitivity to drug components;

• severe kidney and spleen diseases;

• pregnancy;

• lactation period;

• children under 18 years of age.

pharmachologic effect

Panavir is an antiviral and immunomodulatory agent. Increases the body's nonspecific resistance to various infections and promotes the induction of alpha and gamma interferons by blood leukocytes. In therapeutic doses, the drug is well tolerated. Tests have shown the absence of mutagenic, teratogenic, carcinogenic, allergenic and embryotoxic effects. In preclinical studies on laboratory animals, a negative effect on reproductive function and fetal development has not been established. Possesses anti-inflammatory properties in experimental models of exudative edema, chronic proliferative inflammation and in the test of pseudo-allergic inflammatory response to concanavalin A.

Application during pregnancy and lactation

Use with caution during pregnancy. Contraindicated during lactation.

Side effects

In rare cases, allergic reactions are possible. If any unwanted side effects appear or if other side effects are noticed that are not indicated in the instructions, it is necessary to stop the administration of the drug and consult a doctor.

Overdose

Overdose cases have not been registered. The results of preclinical studies indicate the low toxicity of the drug.